자동 세포 셰이커 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Automated Cell Shakers Market Growth & Trends:

The global automated cell shakers market size is expected to reach USD 1.05 billion by 2030, registering a CAGR of 7.10% from 2025 to 2030. This expansion is largely driven by the rising demand for high-throughput biological research. Laboratories and research institutions increasingly adopt automated systems to enhance workflow efficiency and minimize manual errors. Automated cell shakers enable uniform cell growth and precise environmental control, which are crucial in cell-based assays and culture processes. The need for reproducible experimental conditions pushes facilities to replace manual methods with automated technologies. This shift strengthens the demand for cell shakers in academic and industrial research settings.

Biopharmaceutical companies contribute significantly to market expansion through continuous drug development and biologics production investments. These firms require scalable and consistent cell culture processes to support preclinical and clinical testing. Automated cell shakers offer time-saving benefits and ensure consistent mixing, essential for producing quality biological products. Companies integrate automated systems to maintain regulatory compliance and production efficiency as the biopharmaceutical pipeline expands. This trend directly impacts automated cell shaker sales growth across global markets.

The growth of personalized medicine and regenerative therapies creates new opportunities for automated cell shaker technologies. Stem cell research, tissue engineering, and gene therapy rely on stable and controlled culture environments. Automated systems help standardize these processes, ensuring better outcomes and scalability for advanced treatments. Moreover, automation allows labs to handle more samples, reducing turnaround time and increasing productivity. As precision medicine gains traction, automated cell shakers are becoming essential tools in clinical and translational research workflows.

Automated Cell Shakers Market Report Highlights:

• Based on product, the orbital shakers segment is expected to witness the fastest growth, with a CAGR of 9.18% during the forecast period, due to the increasing preference for uniform and efficient cell culture agitation. These devices are widely used in laboratories because they maintain consistent mixing and reduce contamination risk. Their compatibility with various vessel sizes and formats supports flexible experimental setups. The rising need for high-throughput screening in biotechnology and pharmaceutical research further drives the demand. Integrating programmable speed controls and digital interfaces enhances ease of use and process reproducibility. Advancements in motor technology have also improved energy efficiency and durability in these systems.
• Based on application, the drug development segment dominated the market and accounted for the largest revenue share in 2024, driven by the rising focus on precision medicine and biologics. Automated cell shakers are vital in culturing cells used in early-stage drug discovery and efficacy testing. The segment benefits from the growing volume of clinical trials and the increasing complexity of compound screening. Pharmaceutical firms require reliable systems that support consistent cell viability and reduce manual handling. These devices also help maintain optimal growth environments, improving the speed and accuracy of experimental results. The need for scalable and reproducible workflows continues to push demand within this segment.
• Based on end use, the pharmaceutical companies segment held the largest revenue share in 2024, driven by the increasing demand for streamlined bioprocessing in cell-based studies. These companies rely on automated cell shakers for consistent cell culture preparation during research and production. The shift toward automation across lab operations supports time savings and reduces errors in experimental outcomes. The growing pipeline of biologics and biosimilars has further expanded the usage of automated systems for cell expansion. These devices enhance throughput and reduce variability in large-scale production settings. The segment continues to grow with rising investment in R&D infrastructure across pharmaceutical firms.
• North America held the largest market share of 37.49% in 2024 in the automated cell shakers market, primarily driven by the strong presence of the pharmaceutical and biotechnology industries. The region has a high concentration of research institutes and academic centers using automated systems for advanced cell studies. Continuous innovation and adoption of automated lab technologies support market leadership in North America.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Automated Cell Shakers Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Advancements in Laboratory Automation Technology
    • 3.2.1.2. Increasing Demand for Biopharmaceuticals
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Initial Investment Costs
    • 3.2.2.2. Strict Regulatory Compliance
• 3.3. Automated Cell Shakers Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Automated Cell Shakers Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Automated Cell Shakers Market Product Movement Analysis
• 4.3. Global Automated Cell Shakers Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Automated Cell Shakers
  • 4.4.1. Automated Cell Shakers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Orbital Shakers
  • 4.5.1. Orbital Shakers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.6. Benchtop Incubator Shakers
  • 4.6.1. Benchtop Incubator Shakers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.7. Cell Shaker with Rotatory Arms
  • 4.7.1. Cell Shaker with Rotatory Arms Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.8. Accessories
  • 4.8.1. Accessories Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Automated Cell Shakers Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Automated Cell Shakers Market Application Movement Analysis
• 5.3. Global Automated Cell Shakers Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Development
  • 5.4.1. Drug Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. Regenerative Medicine
  • 5.5.1. Regenerative Medicine Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.6. Cell Therapy
  • 5.6.1. Cell Therapy Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.7. Stem Cell Research
  • 5.7.1. Stem Cell Research Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Automated Cell Shakers Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Automated Cell Shakers Market End Use Movement Analysis
• 6.3. Global Automated Cell Shakers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical Companies
  • 6.4.1. Pharmaceutical Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.5. Biopharmaceutical Companies
  • 6.5.1. Biopharmaceutical Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.6. CDMOs & CMOs
  • 6.6.1. CDMOs & CMOs Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.7. Hospitals
  • 6.7.1. Hospitals Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 6.8. Other End Uses
  • 6.8.1. Other End Uses Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. Automated Cell Shakers Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Strategy Mapping
• 8.4. Participants Overview
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Eppendorf AG
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Ohaus Corporation
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Benchmark Scientific
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Corning Incorporated
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Grant Instruments
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Kuhner Shaker
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Infors AG
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Boekel Scientific
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. VELP Scientifica Srl
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives